81 results about "Increased Bone Density" patented technology

The invention provides a nutritional composition and application of the nutritional composition. The nutritional composition comprises medium-chain and long-chain fatty acid triglyceride and a milk fat globule membrane in a mass ratio of (2: 1)-(97: 1), and the medium-chain and long-chain fatty acid triglyceride and the milk fat globule membrane have a synergistic effect in the aspects of promoting skeletal development, especially increasing bone mineral density and / or preventing or treating osteogenesis insufficiency and / or osteoporosis.

The invention discloses a composition for improving bone density and application thereof, and belongs to the technical field of food. According to the invention, the 1, 3-dioleic acid-2-palmitin, the osteopontin and the oligosaccharide are compounded for use, and the components interact to promote mutual absorption and utilization, so that the growth and development of bones in the growth period of infants are improved, the mineral content and the bone mineral density of the bones are increased, the health of the bones is promoted, and the composition is safe and free of side effects. And by optimizing the variety of the oligosaccharide, the compound use of the galactooligosaccharide and the 2 '-fucosyllactose is found to be capable of better improving the growth and development of bones in the growth period of the infants.

The invention relates to the field of food, in particular to colostrum basic protein as well as a preparation method and application thereof. The colostrum basic protein of the present invention can increase bone mass, increase bone density, promote skeletal development, promote skeletal regeneration or repair, promote calcium absorption, promote bone collagen production, and / or prevent and / or treat bone related diseases (such as osteoporosis, osteoporosis, rickets, osteoarthrosis).

The invention discloses a lindera glauca extract, a preparation method thereof and application of the lindera glauca extract in preparation of drugs for preventing and / or treating rheumatoid arthritis. The research finds that the lindera glauca extract can obviously reverse arthritic rat plantar part swelling and toe bending, relieve ankle joint injury, relieve synovial hyperplasia and inflammatory cell infiltration, inhibit joint fusion, relieve joint gap stenosis, relieve articular surface fusion tendency, increase bone mineral density and bone trabecula number, reduce bone trabecula separation degree and improve joint fusion. The lindera glauca extract can be used for relieving rheumatoid arthritis by protecting the inherent structure of joint tissues and improving inflammation, so that a novel natural medicine choice is provided for preventing and / or treating rheumatoid arthritis.

The invention relates to an application of plant lactobacillus Hi188 in promotion of bone health. The invention provides the application of the plant lactobacillus Hi188 or the afterbiogen thereof or the composition thereof in increasing the bone mineral density, increasing the bone mineral density, promoting the skeletal development, increasing the bone mineral content and / or promoting the tibia growth. Or preparing food for increasing bone mineral density, increasing bone mineral density, promoting skeletal development, increasing bone mineral content and / or promoting tibia growth; wherein the composition comprises: (A) Phytobacterium plantarum Hi188 or a postbiotic thereof, and (B) Bifidobacterium lactis Ca360 or a postbiotic thereof.

The application provides a preparation method of non-denatured type II collagen for increasing bone density and improving bone elasticity, and belongs to the technical field of biotechnology. The application adopts EDTA-citric acid buffer containing beta-mercaptoethanol to decalcify cartilage, adopts supercritical CO2 extraction technology to defat, adopts alkaline protease and collagenase II to perform matrix directional enzymolysis, and performs gradient digestion; then three-phase centrifugal separation is adopted to separate non-denatured type II collagen, and biomimetic H column chromatography purification is adopted, so that non-denatured type II collagen with high extraction rate, high purity and high structural integrity can be obtained.

This disclosure relates methods and compositions for preventing bone loss and increasing bone density and strength.

This invention belongs to the field of biotechnology, specifically relating to an osteogenic amino acid fragment Z01 and its screening and applications. This invention utilizes a unique cell screening platform specifically for Osx: the CL-Osx-EGFP cell line. This platform fuses Osx and EGFP, using EGFP as a tracking marker to directly reflect changes in Osx expression and screen for compounds that can activate Osx. Z01 was first discovered to effectively activate Osx, and its amino acid sequence is shown in SEQ ID NO.1. Pharmacokinetic and toxicological analyses were performed on Z01, and its osteogenic activity was verified in an ovariectomized rat osteoporosis model. Ultimately, it was demonstrated that Z01 possesses osteogenic activity, can improve bone microstructure, increase bone density, and has a wide range of applications.

The present invention relates to a novel lappaconitine derivative, a preparation method thereof and a pharmaceutical use utilizing its osteogenesis-promoting activity. The lappaconitine derivative induces differentiation of stem cells into osteoblasts, increases bone density if applied to an osteoporosis animal model, and induces osteogenesis in a fracture animal model, and thus can be effectively used to prevent, improve or treat osteoporosis and other bone-related diseases, as well as to treat non-disease fractures caused by physical trauma.

The invention relates to the technical field of biology, and particularly discloses a composition and application thereof in improving articular cartilage health. The composition comprises sodium hyaluronate, colostrum basic protein and N-acetylglucosamine, wherein the mass ratio of the sodium hyaluronate to the colostrum basic protein to the N-acetylglucosamine is (1-2): (1-2): (1-8). The composition disclosed by the invention can be used for increasing the bone mineral density, increasing the number of osteoblasts, promoting cartilage growth and increasing the content of II-type collagen in an animal body, so that the bone joint function can be effectively improved, and a new method is provided for joint maintenance.

The application discloses a composition for improving bone density and application thereof, and belongs to the technical field of food. The composition is prepared by using 1,3-dioleic acid-2-palmitic acid triglyceride, osteonectin and oligosaccharide in combination, and through the interaction between the components, the absorption and utilization of each other are promoted, the growth and development of the bone of an infant in the growth period are improved, the bone mineral content and bone density are improved, the bone health is promoted, and the composition is safe and has no side effect. Through optimization of the types of the oligosaccharide, it is found that the combination of oligogalactose and 2'-fucosyllactose can better improve the growth and development of the bone of the infant in the growth period.

The invention provides a composition. The composition is prepared from vitamin A, vitamin D, vitamin E, vitamin K and health-care food or food-acceptable auxiliary materials according to specific proportions and doses. The anti-osteoporosis health-care food has the advantages that the vitamin components have a synergistic effect in the aspect of anti-osteoporosis, and the anti-osteoporosis health-care food can increase bone mineral density and maintain bone mass. In addition, the composition disclosed by the invention can also be used for precise nutritional supplement of specific crowds.

According to the spirulina platensis calcium chelating peptide and the application thereof, spirulina platensis is pretreated at high temperature and high pressure and then subjected to enzymolysis, and compared with zymolyte obtained without high temperature and high pressure, the zymolyte obtained after high temperature and high pressure treatment has higher calcium chelating activity. The spirulina platensis peptide calcium chelate with high calcium content is prepared by optimizing the peptide-calcium ratio, temperature, pH and other conditions, and animal experiments prove that the spirulina platensis peptide calcium chelate can significantly improve the bioavailability of calcium ions in osteoporosis mice and increase the bone density. The spirulina platensis calcium chelating peptide provided by the invention is combined with calcium ions to form a peptide-calcium chelate, and animal experiments prove that the peptide-calcium chelate can remarkably improve the calcium absorption rate and the calcium retention rate of osteoporosis mice, improve the bioavailability of the calcium ions in the osteoporosis mice and increase the bone mineral density.

This invention relates to a nutritional composition for promoting bone development and its applications. The invention provides applications of the nutritional composition or preparations comprising said nutritional composition, including: (1) preparing food products; (2) preparing health products for promoting bone development, increasing height, and / or improving bone density; (3) preparing drugs or drug compositions for promoting bone development, increasing height, increasing bone density, treating or preventing osteoporosis, and / or treating or preventing skeletal dysplasia; and (4) promoting bone development, increasing height, and / or improving bone density for non-therapeutic purposes; wherein said nutritional composition comprises medium- and long-chain triglycerides (MLCT) and 1,3-diunsaturated fatty acid-2-palmitoyltriglycerides (UPU).

The present invention relates to the field of biological extraction, and a preparation method of sturgeon cartilage peptide for increasing bone density. The method comprises the following steps: a) pretreating fresh sturgeon cartilage to obtain pretreated cartilage; b) enzymatically hydrolyzing the pretreated cartilage, adding a composite enzyme, adjusting the pH value and controlling the temperature to carry out an enzymatic hydrolysis reaction to obtain an enzymatic hydrolysate; c) centrifugally separating the enzymatic hydrolysate to remove insoluble substances to obtain a supernatant; d) subjecting the supernatant to membrane separation to remove macromolecular impurities to obtain a cartilage peptide concentrate; e) drying the cartilage peptide concentrate to obtain sturgeon cartilage peptide powder. The preparation method comprises steps such as pretreatment, enzymatic hydrolysis, centrifugal separation, membrane separation and drying. The composite enzyme is compounded from protein glutaminase, Lys-C protease and alkaline protease. The method of the present invention is simple, efficient, economical and environmentally friendly, can significantly improve the extraction rate, purity and biological activity of sturgeon cartilage peptide, reduce production costs, and meet market demands. Through experimental verification, the composition of the present invention can significantly increase bone density and effectively prevent and alleviate osteoporosis.

The invention belongs to the technical field of health-care food, and particularly relates to a glucosamine chondroitin bone collagen composition for improving bone and joint functions and a preparation method of the glucosamine chondroitin bone collagen composition. The glucosamine chondroitin collagen composition is characterized by being prepared from the following raw materials in parts by weight: 160 to 200 parts of calcium carbonate, 150 to 200 parts of D-glucosamine hydrochloride, 40 to 50 parts of chondroitin sulfate, 30 to 50 parts of bone collagen powder, 5 to 10 parts of hydroxypropyl methyl cellulose, 10 to 20 parts of sodium carboxymethyl starch and 2 to 8 parts of magnesium stearate. By reasonably controlling the ratio of the D-glucosamine hydrochloride to the chondroitin sulfate and the ratio of the calcium carbonate to the bone collagen powder, a better effect of increasing the bone mineral density is achieved. By reasonably controlling the content of the auxiliary materials, the product has better hardness, disintegration time limit and friability.

The invention provides a micro-fat calcium supplement carrier, which is prepared from the following raw materials in parts by weight: 30 to 35 parts of standard index calcium, 1 to 5 parts of chondroitin, 1 to 5 parts of glucosamine, 8 to 12 parts of pure camel milk, 0.7 part of vitamin D, 2 to 70.3 parts of vitamin K, 1 to 3 parts of phospholipid complex and 8 to 10 parts of excipient. According to the invention, standard calcium, chondroitin, glucosamine, pure camel milk, vitamin D, vitamin K2-7, a phospholipid complex and an excipient are organically mixed by adopting a liposome carrier technology, so that the digestion and absorption of calcium in a body and the distribution of calcium in a specific region are effectively improved, and further the effects of rapid bone growth, increase of bone length (promotion of height increase) and increase of bone density are achieved; the health-care food has the health-care functions of reducing the fracture probability, preventing tooth decay, reducing the death rate of cardiovascular diseases and the like, so that the calcium absorption rate is remarkably improved and reaches up to 95%.

The present invention provides a Pediococcus pentosaceus for regulating mood, improving sleep and increasing height and its application, belonging to the technical field of probiotics. The classification name of the Pediococcus pentosaceus ZJPY017 of the present invention is Pediococcus pentosaceus, which is preserved in the General Microbiological Center of the China Microbiological Culture Collection Administration Committee, and the preservation number is CGMCC No.1.60177. The Pediococcus pentosaceus provided by the present invention has strong acid resistance and bile salt resistance, and has the effects of increasing bone density, helping the body to excrete lead, promoting height growth, regulating mood and improving sleep. It has general applicability to all kinds of people and provides new ideas for the research and development of health foods and medicines.

The invention relates to the technical field of collagen peptide extraction, and particularly discloses a preparation method of fresh bovine bone collagen peptide for increasing bone mineral density, which comprises the following steps: step S1, degreasing treatment; step S2, crude extraction; step S3, performing enzymolysis; step S4, performing supercritical extraction; according to the technical scheme, the extraction promoting liquid is added in the crude extraction process, meanwhile, ultrasonic-assisted synchronous microwave radiation is matched, calcium lactate, lecithin, chlorogenic acid and compound enzyme are added in the enzymolysis process, and the purity and yield of the fresh bovine bone collagen peptide are improved through the synergistic effect of all the procedures.

The application provides a compound preparation for improving osteoporosis and osteoarthritis, a preparation method and application thereof, and belongs to the technical field of biological medicines. The compound preparation contains the following raw materials: glutathione, curcumin, calcium carbonate, vitamin D3, hydrolyzed collagen, and glucosamine sulfate; wherein the glutathione exists in the form of a cyclodextrin inclusion compound. The preparation method comprises the following steps: mixing the calcium carbonate, the hydrolyzed collagen, the glucosamine sulfate and excipients, then adding an equal amount of a premix of the glutathione cyclodextrin inclusion compound, the curcumin and the vitamin D3 in a stepwise manner, and performing dry granulation and tabletting to obtain the compound preparation. The compound preparation can simultaneously increase bone density, protect articular cartilage, reduce the levels of oxidative stress and inflammation, and can be used for preparing medicines or health foods for preventing or adjuvant treating osteoporosis and osteoarthritis. The application has a scientific formula, a stable process and a good application prospect.

The application provides a composition for promoting bone health and bone formation, and application and products thereof, and belongs to the field of food. The composition of the application is composed of 2'-fucosyllactose, osteopontin and a calcium source, wherein the osteopontin is 1-5 parts, the 2'-fucosyllactose is 1-50 parts and the calcium source is 0.05-50 parts by weight. The composition of the application shows a good synergistic effect in promoting calcium absorption, and can be used for increasing bone density, preventing and treating osteoporosis and the like.

The invention discloses a device for treating osteoporosis by compounding electromagnetic field and ultrasonic wave with Disumab, which comprises a base plate, a support bed mattress plate is fixedly mounted on the upper surface of the base plate, a limiting groove is formed in the base plate, and a transmission assembly is movably arranged in the limiting groove. A medicine conveying module, an electromagnetic field generating module and an ultrasonic wave generating module are fixedly arranged on the surface of the transmission assembly, the medicine conveying module, the electromagnetic field generating module and the ultrasonic wave generating module are electrically connected with an external control module, and a display interaction module is arranged in the external control module; the electromagnetic field, ultrasonic waves and medicine assistance are combined, the synergistic effect of multiple treatment means is achieved, the treatment effect on osteoporosis is improved, and compared with a single treatment mode, the bone mineral density can be more rapidly and effectively increased, and the treatment period can be shortened.

The invention provides a bone collagen peptide for increasing bone mineral density and a preparation method thereof, the method comprises the following steps: S1, dispersing bone gelatin in water to obtain a bone gelatin solution; s2, adding a 0.1-1 mol / L acidic pH regulator into the bone gelatin solution at a speed of 1-10 mL / min until the turbidity of the system is increased by 10-20% compared with the turbidity of the initial bone gelatin solution, then stopping adding, standing for 10-30 min, and filtering to obtain a bone gelatin supernatant; s3, adding endoprotease into the bone gelatin supernate to obtain enzymatic hydrolysate; and S4, performing post-treatment and drying on the enzymatic hydrolysate to obtain the bone collagen peptide. According to the method, the mass ratio of the low-molecular-weight polypeptide in the obtained bone collagen peptide can be increased, and the composition of the obtained bone collagen peptide is more suitable for bone metabolism to increase the bone density.

The invention relates to the technical field of traditional Chinese medicines, in particular to application of a traditional Chinese medicine composition in preparation of medicines for treating and / or preventing renal bone diseases. The traditional Chinese medicine composition comprises pseudo-ginseng, ligusticum wallichii, corydalis tuber, radix paeoniae alba, radix achyranthis bidentatae, rhizoma cibotii, rheum officinale and radix angelicae pubescentis. The traditional Chinese medicine composition can significantly improve the damaged renal function and calcium and phosphorus metabolism; the bone mineral density can be effectively increased; the expression level of BMP-7 protein in bone tissues can be increased, and renal bone diseases can be improved. And the preparation method of the compound combination medicine for treating the renal bone diseases is simple, rapid, efficient and easy to operate. The prepared capsules, tablets, granules, pills, injections and the like are convenient to carry and take.

The invention relates to a composition with a function of improving bone mineral density, application of the composition and a preparation method of related health-care products or foods, and the composition comprises the following components in parts by weight: 0.5-4.5 parts of D-glucosamine hydrochloride, 0.5-3 parts of calcium carbonate, 0.1-1.5 parts of sodium chondroitin sulfate, 0.5-2.5 parts of American ginseng extract, 0.2-2 parts of salvia miltiorrhiza extract, 0.15-1.5 parts of radix paeoniae alba extract and 0.1-1 part of turmeric extract. The composition is prepared into a medicine, a health care product or a food to increase the bone mineral density. According to the composition, green, natural and high-quality raw materials and auxiliary materials are selected, the composition is prepared from the perspective of traditional Chinese medicine, modern nutriology and modern pharmacology, calcium supplement, articular cartilage protection and inflammation relieving are integrated, the formula plays a comprehensive role in increasing the bone mineral density in different links, and the effect of increasing the bone mineral density under the effect of three pipes is achieved. The composition can be prepared into medicines, health-care products or foods, the preparation process is simple, and the prepared product is green, safe and remarkable in curative effect and has a good market prospect.

The present invention addresses the problem of providing a means that is effective against osteoporosis caused by various causes. Provided are: a composition that is for treatment of osteoporosis and that comprises any one of lactic acid bacteria belonging to the genus Lactococcus and / or a fermentation product of any one of lactic acid bacteria belonging to the genus Lactococcus; and a composition for any one selected from the group consisting of increase in bone strength, inhibition of a decrease in bone strength, increase in bone density, inhibition of a decrease in bone density, enhancement of bone quality, inhibition of a decrease in bone quality, enhancement of bone structure, inhibition of a decrease in bone strength, promotion of bone formation, inhibition of a decrease in bone formation, decrease in bone resorption, and inhibition of an increase in bone resorption. The lactic acid bacteria belonging to the genus Lactococcus preferably belong to Lactococcus lactis subsp. lactis.

Disclosed herein are compounds and methods for treating Osteogenesis Imperfecta in an individual. In some embodiments, the compounds include a bone anabolic agent, a linker, and a bone targeting ligand. In some embodiments, the methods include reducing the incidences of or likelihood of bone fracture, increasing bone density or strength of a bone, and providing compounds to low density and weakened bone sites in an individual with Osteogenesis Imperfecta.

The application provides a kind of cartilage polypeptide composition and its preparation method, the cartilage polypeptide 30-45%, auxiliary agent 10-25%, growth agent 3-8%, slow-release agent 2-9%, the balance is water, the application will cartilage polypeptide, auxiliary agent, growth agent and slow-release agent several ingredients scientific compatibility, preparation has the composition of protecting cartilage tissue, anti-inflammatory pain, effectively increase bone density effect, improve synovial tissue, there is no rebound ineffective condition after drug withdrawal.

This application provides a collagen peptide for increasing bone density and a method for preparing the same. The method includes the following steps: S1: dispersing bone gelatin in water to obtain a bone gelatin solution; S2: adding 0.1-1 mol / L acidic pH adjuster to the bone gelatin solution at a rate of 1-10 mL / min until the turbidity of the system increases by 10%-20% compared to the initial bone gelatin solution, then stopping the addition, allowing it to stand for 10-30 min, and filtering to obtain a bone gelatin supernatant; S3: adding an endopeptide to the bone gelatin supernatant to obtain an enzymatic hydrolysate; S4: post-processing and drying the enzymatic hydrolysate to obtain collagen peptides. This method can increase the mass ratio of low molecular weight peptides in the obtained collagen peptides, resulting in a composition of collagen peptides more suitable for bone metabolism and utilization to increase bone density.

This invention discloses the application of PT-129 in the preparation of drugs for treating rheumatoid arthritis (RA), belonging to the field of RA treatment. This invention is the first to demonstrate that the compound PT-129 can target and intervene in the synovial microenvironment, effectively inhibiting the abnormal activation behaviors of RA fibroblast-like synovial cells (FLS) such as proliferation, migration, and invasion, and downregulating the expression of N-cadherin and MMP3 proteins in synovial tissue. This invention provides a combined drug formulation containing PT-129 and RGFP966. This composition exhibits a significant synergistic effect in vivo, effectively relieving joint swelling, increasing bone density and trabecular bone thickness, reducing trabecular bone separation, thereby inhibiting cartilage degradation and bone destruction. This invention provides a novel targeted drug and combination therapy with definite efficacy for the clinical intervention of RA, possessing extremely high clinical application development value.